You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

An Endorsement of the 2025 Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the EOTTD, ESGO, GCIG, ISSTD

ID: GL END 4-19 nov 2025
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
G. Bouchard-Fortier, D. Sivajohanathan, N. Coakley, M. Cesari, L. Eiriksson, A. Lohman, S. Ferguson, The Ontario Gynecologic Cancers Advisory Committee

Guideline Objective

To make recommendations regarding the diagnosis, treatment and follow-up of patients with pre-malignant and malignant gestational trophoblastic disease (GTD).

Patient Population

Individuals with a confirmed or suspected diagnosis of GTD.

Intended Guideline Users

All healthcare providers involved in the care of patients with GTD.

pdf download Full Report (PDF) (285.5 Ko)